Literature DB >> 12884290

The mer receptor tyrosine kinase: expression and function suggest a role in innate immunity.

Edward M Behrens1, Paul Gadue, Shun-you Gong, Stacey Garrett, Paul L Stein, Philip L Cohen.   

Abstract

The mer receptor tyrosine kinase mediates phagocytosis of apoptotic cells and modulates cytokine production; it is also required for prevention of systemic autoimmune disease. Using a mer-specific antibody, we have confirmed the presence of mer on macrophages and now report its expression on NK cells, NKT cells, and dendritic cells (DC). We found that DC do not require mer for ingestion of apoptotic cells, as DC from mer-deficient mice phagocytose apoptotic cells normally. Mer was observed in splenic sections on cells outside follicular areas, probably representing DC and macrophages. Mer apparently participates in NKT-cell antigen-induced signaling, as NKT cells from mer-deficient mice evinced much lower cytokine production after in vivo alpha-galactosylceramide stimulation; this defect was intrinsic to the mer-deficient NKT cells. Taken together, these studies show mer expression on cells of the innate immune system. Mer, through its binding of lipid antigens, may not only mediate ingestion of apoptotic cells, but also signal events in NK cells, NKT cells, and DC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884290     DOI: 10.1002/eji.200324076

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  52 in total

1.  Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly.

Authors:  Jeffrey H Jennings; Derek J Linderman; Bin Hu; Joanne Sonstein; Jeffrey L Curtis
Journal:  Am J Respir Cell Mol Biol       Date:  2004-11-24       Impact factor: 6.914

2.  Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.

Authors:  Adil Anwar; Amy K Keating; David Joung; Susan Sather; Grace K Kim; Kelly K Sawczyn; Luis Brandão; Peter M Henson; Douglas K Graham
Journal:  J Leukoc Biol       Date:  2009-04-22       Impact factor: 4.962

3.  Overexpression of apoptotic cell removal receptor MERTK in alveolar macrophages of cigarette smokers.

Authors:  Angeliki Kazeros; Ben-Gary Harvey; Brendan J Carolan; Holly Vanni; Anja Krause; Ronald G Crystal
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-27       Impact factor: 6.914

Review 4.  Immunobiology of the TAM receptors.

Authors:  Greg Lemke; Carla V Rothlin
Journal:  Nat Rev Immunol       Date:  2008-05       Impact factor: 53.106

Review 5.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

6.  MERTK as negative regulator of human T cell activation.

Authors:  Raquel Cabezón; E Antonio Carrera-Silva; Georgina Flórez-Grau; Andrea E Errasti; Elisabeth Calderón-Gómez; Juan José Lozano; Carolina España; Elena Ricart; Julián Panés; Carla Vanina Rothlin; Daniel Benítez-Ribas
Journal:  J Leukoc Biol       Date:  2015-01-26       Impact factor: 4.962

7.  Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells.

Authors:  Manuel D Galvan; Deborah B Foreman; Erliang Zeng; John C Tan; Suzanne S Bohlson
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

8.  Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.

Authors:  Gaetano Zizzo; Brendan A Hilliard; Marc Monestier; Philip L Cohen
Journal:  J Immunol       Date:  2012-08-31       Impact factor: 5.422

9.  Is the TAM receptor Axl a receptor for lymphocytic choriomeningitis virus?

Authors:  Brian M Sullivan; Megan J Welch; Greg Lemke; Michael B A Oldstone
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

Review 10.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.